PI
CRL icon

Putnam Investments’s Charles River Laboratories CRL Stock Holding History

Putnam Investments’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-37,726
Closed -$4.76M – 884
2020
Q1 		$4.76M Sell
37,726
-556
-1% -$83.4K 0.01% 449
2019
Q4 		$5.85M Sell
38,282
-253
-0.7% -$35K 0.01% 475
2019
Q3 		$5.1M Buy
38,535
+491
+1% +$65.8K 0.01% 499
2019
Q2 		$5.4M Sell
38,044
-46
-0.1% -$6.24K 0.01% 500
2019
Q1 		$5.53M Sell
38,090
-1,131
-3% -$149K 0.01% 483
2018
Q4 		$4.44M Sell
39,221
-31,733
-45% -$3.97M 0.01% 492
2018
Q3 		$9.55M Buy
70,954
+41
+0.1% +$5.06K 0.02% 401
2018
Q2 		$7.96M Buy
70,913
+680
+1% +$73.5K 0.02% 419
2018
Q1 		$7.5M Buy
70,233
+514
+0.7% +$55.4K 0.02% 427
2017
Q4 		$7.63M Buy
69,719
+1,224
+2% +$133K 0.02% 430
2017
Q3 		$7.4M Sell
68,495
-5,126
-7% -$527K 0.02% 438
2017
Q2 		$7.45M Sell
73,621
-6,499
-8% -$598K 0.02% 436
2017
Q1 		$7.21M Sell
80,120
-46,256
-37% -$3.93M 0.02% 470
2016
Q4 		$9.63M Sell
126,376
-456
-0.4% -$34.6K 0.02% 385
2016
Q3 		$10.6M Sell
126,832
-13,933
-10% -$1.17M 0.03% 370
2016
Q2 		$11.6M Buy
140,765
+5,055
+4% +$416K 0.03% 380
2016
Q1 		$10.3M Buy
135,710
+43,197
+47% +$3.2M 0.02% 432
2015
Q4 		$7.44M Buy
92,513
+42,248
+84% +$3.05M 0.02% 541
2015
Q3 		$3.19M Buy
+50,265
New +$3.61M 0.01% 834
2015
Q2 		– Sell
-57,305
Closed -$4.54M – 1501
2015
Q1 		$4.54M Sell
57,305
-199
-0.3% -$14.7K 0.01% 806
2014
Q4 		$3.66M Sell
57,504
-335
-0.6% -$21K 0.01% 860
2014
Q3 		$3.46M Sell
57,839
-9
-0% -$515 0.01% 889
2014
Q2 		$3.1M Buy
+57,848
New +$3.17M 0.01% 921

Other funds holding CRL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Putnam Investments's CRL Position: Q2 2020 in Review

Putnam Investments sold out of Charles River Laboratories (CRL) in Q2 2020, closing a stake of 37,726 shares — an estimated $4.76M sold.

Putnam Investments first reported a position in CRL in Q2 2014 and held it in 23 quarters. The position peaked at $11.6M in Q2 2016. 466 funds tracked by Wall St. Rank hold CRL as of Q2 2020.

  • Putnam Investments reported no remaining Charles River Laboratories position as of Q2 2020 after selling out during the quarter.
  • Putnam Investments sold 37,726 Charles River Laboratories shares in Q2 2020, an estimated $4.76M.
  • Putnam Investments first reported a position in Charles River Laboratories in Q2 2014 and held it in 23 quarters.
  • Putnam Investments's Charles River Laboratories position peaked at $11.6M in Q2 2016.
  • 466 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2020.

Based on Putnam Investments's 13F filing for Q2 2020, filed 14 Aug 2020.